GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » Total Assets

Poly Medicure (NSE:POLYMED) Total Assets : ₹18,587 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure Total Assets?

Poly Medicure's Total Assets for the quarter that ended in Mar. 2024 was ₹18,587 Mil.

Warning Sign:

If a company builds assets at 21% a year, faster than its revenue growth rate of 15.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Poly Medicure's average Total Assets Growth Rate was 22.20% per year. During the past 3 years, the average Total Assets Growth Rate was 22.40% per year. During the past 5 years, the average Total Assets Growth Rate was 21.00% per year. During the past 10 years, the average Total Assets Growth Rate was 18.60% per year.

During the past 13 years, Poly Medicure's highest 3-Year average Total Assets Growth Rate was 23.80%. The lowest was 15.80%. And the median was 19.40%.

Total Assets is connected with ROA %. Poly Medicure's annualized ROA % for the quarter that ended in Mar. 2024 was 14.71%. Total Assets is also linked to Revenue through Asset Turnover. Poly Medicure's Asset Turnover for the quarter that ended in Mar. 2024 was 0.20.


Poly Medicure Total Assets Historical Data

The historical data trend for Poly Medicure's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure Total Assets Chart

Poly Medicure Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,673.25 12,237.31 13,768.35 15,772.09 18,586.72

Poly Medicure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,772.09 - 16,971.76 - 18,586.72

Poly Medicure Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Poly Medicure's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=14700.535+3886.184
=18,587

Poly Medicure's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=14700.535+3886.184
=18,587

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poly Medicure  (NSE:POLYMED) Total Assets Explanation

Total Assets is connected with ROA %.

Poly Medicure's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2734.316/( (0+18586.719)/ 1 )
=2734.316/18586.719
=14.71 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Poly Medicure's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=3780.742/( (0+18586.719)/ 1 )
=3780.742/18586.719
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Poly Medicure Total Assets Related Terms

Thank you for viewing the detailed overview of Poly Medicure's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure (NSE:POLYMED) Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines